In type-2 diabetes (T2D) and Parkinson's disease (PD), polypeptide assembly into amyloid fibers plays central roles: in PD, α-synuclein (aS) forms amyloids and in T2D, amylin [islet amyloid polypeptide (IAPP)] forms amyloids. Using a combination of biophysical methods in vitro we have investigated whether aS, IAPP, and unprocessed IAPP, pro-IAPP, polypeptides can cross-react. Whereas IAPP forms amyloids within minutes, aS takes many hours to assemble into amyloids and pro-IAPP aggregates even slower under the same conditions. We discovered that preformed amyloids of pro-IAPP inhibit, whereas IAPP amyloids promote, aS amyloid formation. Amyloids of aS promote pro-IAPP amyloid formation, whereas they inhibit IAPP amyloid formation. In contrast, mixing of IAPP and aS monomers results in coaggregation that is faster than either protein alone; moreover, pro-IAPP can incorporate aS monomers into its amyloid fibers. From this intricate network of cross-reactivity, it is clear that the presence of IAPP can accelerate aS amyloid formation. This observation may explain why T2D patients are susceptible to developing PD.
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α-synuclein | fluorescence | amyloid | atomic force microscopy | amylin P arkinson's disease (PD) is the second most common neurological disorder and the most common movement disorder. It is characterized by widespread degeneration of subcortical structures of the brain, especially dopaminergic neurons in the substantia nigra. These changes are coupled with bradykinesia, rigidity, and tremor, resulting in difficulties in walking and abnormal gait in patients (1) . The assembly process of the intrinsically unstructured 140-residue protein α-synuclein (aS) into amyloid fibers has been linked to the molecular basis of PD. aS is a major component of amyloid aggregates found in Lewy body inclusions, which are the pathological hallmark of PD, and duplications, triplications, and point mutations in the aS gene are related to familial PD cases (2, 3) . The exact function of aS is unknown, but it is suggested to be involved in synaptic vesicle release and trafficking, regulation of enzymes and transporters, and control of the neuronal apoptotic response (4, 5) . aS is present at presynaptic nerve terminals (6) (7) (8) and, intriguingly, also in many cells outside the brain (e.g., red blood cells and pancreatic β-cells). aS can assemble via oligomeric intermediates to amyloid fibrils under pathological conditions (9) . Although soluble aS oligomers have been proposed to be toxic (10, 11) , work with preformed aS fibrils has demonstrated that the amyloid fibrils themselves are toxic and can be transmitted from cell to cell and are also able to cross the blood-brain barrier (12) (13) (14) .
Type-2 diabetes (T2D) is another disease involving amyloid formation. Here, the primary pathological characteristic is islet amyloid of the hormone amylin, also known as islet amyloid polypeptide (IAPP), in pancreatic β-cells (15) (16) (17) (18) . The process of islet amyloid formation (19) (20) (21) leads to pancreatic β-cell dysfunction, cell death, and development of diabetes. IAPP (37 residues, natively unfolded) is cosecreted with insulin after enzymatic maturation of prohormones pro-IAPP (67 residues) and proinsulin in secretory granules. IAPP and insulin play roles in controlling gastric emptying, glucose homeostasis, and in the suppression of glucagon release. Although not understood on a mechanistic level, impairment of prohormone processing has been thought to play a role in initiation and progression of T2D (22, 23) . Insulin and pro-IAPP (22, (24) (25) (26) , but not proinsulin, can inhibit IAPP amyloid formation in vitro and in mice, suggesting that accumulation of unprocessed proinsulin may promote IAPP amyloid formation (22, 24) . Insulin-degrading enzyme (IDE) is a conserved metallopeptidase that can degrade insulin and a variety of other small peptides including IAPP in the pancreas (27, 28) . Genome-wide association studies have linked IDE to T2D (29, 30) and Ide mutant mice were found to have impaired glucose-stimulated insulin secretion as well as increased levels of IAPP, insulin, and, surprisingly, aS in pancreatic islets (31, 32) . Here, aS may be associated with insulin biogenesis and exocytic release, as it was found to localize with insulin-secretory granules in pancreatic β-cells (33) . We recently demonstrated in vitro that IDE readily inhibits aS amyloid formation via C-terminal binding and, in parallel, IDE activity toward insulin and other small substrates increases (34, 35) .
Together, the key role of aS in PD and the inverse correlation of impaired insulin secretion and increased aS levels in the pancreatic β-cells, imply that PD and T2D may be connected. In support, reports have suggested that patients with T2D are predisposed toward PD (36, 37) . For Alzheimer's disease (AD), a direct link with T2D was found (15, 38) . Amyloid fiber seeds of the AD peptide, amyloid-β, were shown to efficiently accelerate amyloid formation of IAPP in vitro (39, 40) and IAPP was part of amyloid-β plaque found in mice brains (41) . To address the unexplored question of cross-reactivity between the amyloidogenic peptides in PD and T2D, we here investigated crossreactivity among aS, IAPP, and pro-IAPP using biophysical methods in vitro.
Significance
Protein assembly into ordered so-called amyloid fibers is a process that promotes several neurodegenerative disorders, such as Alzheimer's and Parkinson's disease (PD). Also type-2 diabetes (T2D) is a disease involving amyloid formation, although it occurs in the pancreas. Since the protein that forms amyloids in PD, α-synuclein (aS), is also expressed in the pancreas, we investigated whether it could affect aggregation of the peptide involved in T2D, and vice versa. Using in vitro methods and purified proteins, we here demonstrate that the two proteins cross-react and, importantly, the T2D amyloid protein (both as monomer and amyloid seed) can accelerate aS aggregation. This result provides a possible explanation for why patients with T2D are more prone to getting PD.
Results and Discussion
Individual Protein Aggregation Reactions. IAPP, pro-IAPP, and aS all form amyloid fibers in vitro upon incubation at pH 7, 37°C. With agitation, aS (70 μM) aggregates with a lag time of about 20 h (Fig. 1A) , whereas pro-IAPP (140 μM) has a longer lag time of about 30 h (Fig. 1B) . For IAPP, amyloid formation is much faster, with lag times of 5-10 min for 5 μM and 1-2 min for 10 μM IAPP (Fig. 1C) . One may speculate that variation in the intrinsic amyloid formation speed is dependent on the ratio of amyloid-forming segment size over total length of the peptide (which will be highest for IAPP), as fluctuating peptides extending from the amyloid fiber core may slow down secondary nucleation. The resulting amyloid fibers have cross-sections of about 3-4 nm for IAPP and pro-IAPP, but 7-9 nm for aS ( Fig. 1 D-F and Table 1 ). Reported amyloid fiber dimensions for IAPP are ∼5 nm for single fibers (42) (43) (44) . For aS, the just-released solid-state NMR structure of full-length aS amyloid has a core dimension of ∼4.5 nm, surprisingly, with its β-strands arranged in a Greek Key motif (45) . This information implies that our larger aS amyloids may be assemblies of more than one aS proto-fibril. We found that in all three cases (aS, IAPP, and pro-IAPP), preformed amyloid fiber seeds, speed up aggregation of monomers of the same protein ( Fig. 1 B and C ; not shown for IAPP as the seeded reaction is too fast to capture by manual mixing).
Cross-Seeding of Amyloid Formation. Next we tested the possibility of cross-seeding of one protein's amyloid formation reaction with preformed amyloid seeds of another protein. We found that preformed IAPP amyloid seeds speed up aS amyloid formation ( Fig. 2A) , and preformed aS amyloid seeds speed up pro-IAPP amyloid formation (Fig. 2B) , whereas preformed aS amyloid seeds inhibit IAPP amyloid formation (Fig. 2 C and G) , and preformed pro-IAPP amyloid seeds inhibit aS amyloid formation (Fig. 2 D and H) . The resulting amyloid fibers (from reactions in Fig. 2 A and B) have the dimensions matching that of the aggregating protein when aggregating alone (Table 1 and Fig. 2 E and F). This implies that added amyloid fiber seeds (when containing a protein that has an intrinsically faster amyloid formation reaction than the monomeric protein it is mixed with) trigger the "normal" aggregation reaction. In contrast, when amyloid fiber seeds of a protein that forms amyloid fibers slower than the protein it is mixed with (i.e., aS amyloid fiber seeds added to IAPP monomers, and pro-IAPP amyloid fiber seeds added to aS monomers; Fig. 2 C and D) are added, the outcome is instead reduction of amyloid formation.
Coaggregation of aS and Pro-IAPP. When monomers of pro-IAPP are added to aS aggregation reactions, the pro-IAPP monomers inhibit aS aggregation in a concentration-dependent manner (Fig. 3A) . Notably, under these conditions, pro-IAPP itself does not form amyloid fibers. Thus, like the pro-IAPP seeds (Fig. 2D) , pro-IAPP monomers block aS from aggregation and the atomic force microscopy (AFM) images lack amyloids or oligomers (Fig. 3D) . In contrast, if aS monomers are added to high concentrations of pro-IAPP (concentration that aggregates with lag time of 30 h), the resulting thioflavin T (ThT) emission becomes significantly increased but the lag time remains the same (Fig. 3B ). This finding implies that aS monomers become incorporated into the pro-IAPP amyloids without effect on formation speed but allowing for increased ThT emission. The increased ThT emission may be due to better ThT binding to resulting mixed amyloid fibers or simply more amyloids are made. Notably, as aS alone (at 70 μM) would have a lag time of 20 h, and such a process is lacking in Fig. 3B , interactions of aS with pro-IAPP (monomers, oligomers, and protofibrils) must overrule independent aS amyloid formation. This conclusion correlates with the finding that pro-IAPP monomers (at concentrations not readily assembling into fibers) added to aggregating aS monomers, result in aS amyloid 
Short clustering
Amyloid fiber height is a rough estimate that is based on Z measurements of 15-20 individual fibers in each case (distributions shown in Fig. S3 ). Morphology is based on visual inspection of a number of AFM images for each sample and reports the most common features observed throughout. inhibition (Fig. 3A) . In essence, therefore, aS amyloid formation becomes slowed down when monomers are added to high concentrations of pro-IAPP and instead pro-IAPP is capable of recruiting the aS monomers into its amyloid fibers. AFM images of these mixtures imply that thicker fibrils are formed (8-10 nm) compared with the fibrils of pro-IAPP alone ( Fig. 3E and Table 1 ).
Coaggregation of aS and IAPP. Similar to the mixing of aS and pro-IAPP monomers, we found increased ThT emission for IAPP amyloid formation reactions when monomeric aS was added (Fig. 3C) . Notably, because IAPP amyloid formation occurs within 10-20 min, the added aS will not aggregate at all by itself under these conditions. Intriguingly, not only did the ThT emission increase when aS monomers were added to IAPP monomers, also at a ratio of aS to IAPP of 2:1 (5 μM IAPP), but the lag time was also shortened to a few minutes (similar to what was observed when IAPP concentration was increased, compare Fig. 1C with Fig. 3C ). The increased ThT emission and reduced lag time strongly argue that IAPP and aS readily coaggregate and that such reactions are favorable with respect to both speed and amount. In control experiments of IAPP and aS monomers mixed in the plate reader, we found the endpoint ThT signal (after 30 min) to follow the same trend as observed for the same mixtures in kinetic cuvette experiments (Fig. S1) .
AFM images of these mixtures suggest that the resulting amyloid fibers have a thickness of only ∼2 nm, which is thinner than what we observe for the two homoprotein amyloids ( Table 1) . The resulting amyloid fibers in the aS-IAPP mixture appear needle-like with rough, but sharp, edges according to thorough AFM image inspection ( Fig. 3F ; we note that AFM quantification, apart from the Z height, is uncertain). In contrast to the typical amyloids formed by IAPP and aS individually, the amyloid fibers formed in mixtures of the two monomers are very fragile: the AFM tip easily destroys these fibers. Therefore, the tapping mode imaging was possible only at instrument settings that corresponded to the exposure to weak forces. The differences in amyloid fiber morphology, together with the altered reaction kinetics, strongly argue for the formation of coassembled amyloids of aS and IAPP.
Addition of aS monomers to aggregating IAPP after the ThT emission plateau was reached (i.e., at 20 min; IAPP amyloids already formed) did not result in further ThT increase within the time frame of hours (Fig. S2 ). This result demonstrates that the process in Fig. 3C involves coaggregation of monomers, or early assemblies of the two proteins, and is not due to initial formation of IAPP amyloids that subsequently template aS aggregation. Labeling experiments will address the arrangement of IAPP and aS monomers within the heterologous amyloids (work in progress).
Conclusions
Although most studies of amyloid formation have focused on individual disease-specific peptides, interactions of peptides associated with different amyloid diseases may modulate amyloid formation pathways and pathogenicity (38) . IAPP and amyloid-β share 50% sequence similarity and were found to cross-react both in vitro (40) and in vivo (41) . Also peptides structurally and physiologically unrelated, such as IAPP and the amyloidogenic determinant of the prion protein (PrP), can cross-react into morphologically distinct amyloid aggregates (46) and amyloid-β fibers can seed aS amyloid formation (47) . aS is present in the pancreas (33), its levels are inversely correlated with that of IDE (31) , and IDE inhibits aS amyloid formation in vitro (34, 35) . Despite these facts, putative cross-talk between aS and processed and/or unprocessed IAPP has not been addressed previously. The importance of possible cross-reactivity between these proteins is also underscored by recent reports demonstrating that IAPP is present in brain cells and may form amyloidogenic deposits there, although the IAPP peptide appeared to be synthesized elsewhere (41, (48) (49) (50) .
In addition to the intriguing coaggregation detected among monomers, readily forming heterologous amyloid fibers, a trend we discovered was that preformed amyloid fiber seeds from a faster/ slower aggregating protein will accelerate/inhibit aggregation of an intrinsically slower/faster aggregating protein (summarized in Fig. 4 ). This trend may be explained by a built-in "memory" in the amyloid seed (envisioned as fine structural differences) that becomes transmitted into newly formed amyloids and thereby dictates the aggregation speed of the other protein.
With more structural studies of amyloids at atomic resolution, such microscopic variations may eventually be revealed. Finally, our findings provide a simple justification for why T2D is a risk factor for PD (as IAPP amyloid seeds, present in T2D, trigger aS amyloid formation), whereas patients with PD are not prone to getting T2D (aS amyloid seeds, present in PD, inhibit IAPP amyloid formation) (36, 37) . Because aS and IAPP may come in contact with each other both in pancreatic β-cells (33) and in various brain cells (48) (49) (50) , and amyloidogenic assemblies may spread from cell to cell (51) , in vivo studies are desired to reveal the biological consequences of the cross-reactivity detected here.
Materials and Methods
Proteins. aS was purified as described previously (52) . The protein was freeze dried and dissolved in the appropriate buffer before use, followed by filtration through a 0.2-μm filter. Pro-IAPP was purchased from Severn Biotech (product no. SBP0022). IAPP was obtained from Calbiochem (product no. 05-23-2540). Both pro-IAPP and IAPP were treated with hexafluoroisopropanol (105228; Sigma-Aldrich) before use to dissolve any preexisting aggregates. Amyloid seeds of each protein were prepared by incubating aggregated protein samples (i.e., the products of a normal amyloid formation reaction) for 10 s in a sonicating bath. The incubation time has to be optimized for different sonicators because the power output can vary depending on the manufacturer (extended sonication can completely destroy fibrils). Amyloid seeds were characterized by AFM before use.
Amyloid Formation Assay. aS and pro-IAPP amyloid formation reactions were conducted in a plate reader (Fluostar Optima; BMG Labtech) in TBS (0.05 M Tris HCl buffer, pH 7.4 with 0.15 M NaCl, 93318; Sigma-Aldrich) buffer in the presence of 20 μM ThT (T3516; Sigma-Aldrich) at 37°C with agitation and a 2-mm glass bead in each well. Samples were typically incubated for 60 h and fluorescence was measured every 20 min. Due to its faster aggregation kinetics, IAPP amyloid formation was monitored in a 1-cm cuvette using a Cary Eclipse spectrophotometer (with a magnetic stir bar). IAPP aggregation was initiated by pipetting a small volume of IAPP from the 2.5 mM stock (in hexafluoroisopropanol) into the reaction buffer (10 μM ThT in TBS) followed by fluorescence measurements every 30 s. Comparison of endpoint ThT values for IAPP amyloid formation in a cuvette and in the plate reader suggested that the IAPP aggregation process was similar in both setups. For both plate reader and cuvette experiments, ThT was excited at 440 nm and emission was recorded at 480 nm. All reported ThT curves are averages of triplicate experiments, and all experiments were performed (in triplicate) three independent times. (For all of the mixture experiments of monomers/amyloid seeds of two proteins in various combinations, a range of concentrations was tested. The included figures show representative data that illustrate the trends we discovered from a number of experimental conditions.) AFM. Aggregated samples were diluted into Milli-Q water (10-20 times) and deposited on freshly cleaved mica. After 10 min, the mica was rinsed with filtered Milli-Q water and dried under a gentle nitrogen stream. Images were recorded on an NTEGRA Prima setup (NT-MDT) using a gold-coated single crystal silicon cantilever (NSG01, spring constant of ∼5.1 N/m; NT-MDT) and a resonance frequency of ∼180 kHz. The 512-pixel images were acquired with a 0.5-Hz scan rate. Images were analyzed using the WSxM 5.0 software (53) .
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